C-Biomex
C-Biomex is a biotech drug development company that provides diagnostic therapy and radiopharmaceuticals.
C-Biomex is active in the biotechnology, medical, pharmaceutical space based in Asia-Pacific (APAC), founded in 2017.
Its activity falls under biotechnology, medical, pharmaceutical; the profile below is assembled from public directory data.
The company is recorded as being based in Asia-Pacific (APAC).
The company is listed at the Series_B stage of development.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $6.5B.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | series_b |
| Total funding | $6,500,000,000 |
Website: www.cbiomex.com
Sign in to view the contact information we hold for C-Biomex.
Create a free account
Create a free account